Objective: To evaluate the impact of early gastroscopy-assisted nasoenteric tube nutritional support on aspiration and prognosis in patients with hypertensive cerebral hemorrhage.
Methods: A total of 150 patients with hypertensive cerebral hemorrhage (December 2021-December 2023) were randomized into a control group (n=75) receiving nasogastric tube nutritional support and a study group (n=75) receiving gastroscopy-assisted nasoenteric tube nutritional support. Outcomes included the incidence of aspiration and aspiration pneumonia, aspiration risk (assessed by the ICU aspiration risk scale), nutritional indicators (hemoglobin, albumin, pre-albumin, and transferrin), and prognostic scores (GCS and APACHE II).
Results: The study group had significantly lower incidence rates of aspiration (8.00%) and aspiration pneumonia (6.67%) compared with the control group (33.33% and 20.00%, respectively, P <0.05). Preintervention measures showed no significant differences between groups ( P >0.05). Postintervention (weeks 1 and 2), the study group exhibited significantly improved aspiration risk scores, higher nutritional indicator levels, and better prognostic outcomes (higher GCS scores and lower APACHE II scores) compared with the control group ( P <0.05).
Conclusions: Gastroscopy-assisted nasoenteric tube nutritional support reduces aspiration risk and incidence in patients with hypertensive cerebral hemorrhage, enhancing nutritional status and improving prognosis.
扫码关注我们
求助内容:
应助结果提醒方式:
